A 65-year-old with unprovoked PE and low bleeding risk is finishing 6 months of apixaban. What dose is appropriate for extended phase?...

Question

A 65-year-old with unprovoked PE and low bleeding risk is finishing 6 months of apixaban. What dose is appropriate for extended phase?

Accepted Answer

Consider reduced-dose apixaban 2.5 mg bid for extended phase

Answer

Stop anticoagulation now

Answer

Continue full-dose apixaban 5 mg bid only

Answer

Switch to aspirin only

Answer

Warfarin indefinitely

us-abim MCQ (SBA): Extended VTE Therapy